Search Results - "Crinière, E."
-
1
Temozolomide As Initial Treatment for Adults With Low-Grade Oligodendrogliomas or Oligoastrocytomas and Correlation With Chromosome 1p Deletions
Published in Journal of clinical oncology (01-08-2004)“…To determine the response rate of low-grade oligodendroglial tumors (LGOT) to temozolomide (TMZ) as initial treatment and to evaluate the predictive value of…”
Get full text
Journal Article -
2
Correlations between molecular profile and radiologic pattern in oligodendroglial tumors
Published in Neurology (28-12-2004)“…To investigate possible correlations between tumor location and genetic alterations in a series of oligodendrogliomas. A series of 158 consecutive…”
Get full text
Journal Article -
3
All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2
Published in Neurology (08-06-2010)“…Recently, the gene encoding the human cytosolic NADPH-dependent isocitrate dehydrogenase (IDH1) was reported frequently mutated in gliomas. Rare mutations were…”
Get full text
Journal Article -
4
Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification
Published in Neuropathology and applied neurobiology (01-02-2005)“…The expression of Olig2, a basic helix–loop–helix (bHLH) transcription factor involved in oligodendroglial specification, was investigated by…”
Get full text
Journal Article -
5
Multidrug resistance-associated protein MRP1 expression in human gliomas: chemosensitization to vincristine and etoposide by indomethacin in human glioma cell lines overexpressing MRP1
Published in Journal of neuro-oncology (2004)“…The 190 kDa multidrug resistance protein MRP1 is likely to be involved in the multidrug resistance phenotype of human gliomas. MRP1 expression was evaluated in…”
Get full text
Journal Article -
6
α-Internexin expression identifies 1p19q codeleted gliomas
Published in Neurology (13-01-2009)“…alpha-Internexin (INA) is a proneural gene encoding a neurofilament interacting protein that is upregulated in some gliomas, particularly oligodendrogliomas…”
Get full text
Journal Article -
7
Telomerase reactivation in malignant gliomas and loss of heterozygosity on 10p15.1
Published in Neurology (10-06-2003)“…An inhibitor of telomerase activity maps to chromosome 10p15.1. A series of 51 high-grade gliomas was analyzed for loss of heterozygosity (LOH) on chromosome…”
Get full text
Journal Article -
8
Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice
Published in British journal of cancer (15-12-2003)“…In order to develop preclinical models of malignant astrocytomas and oligodendrogliomas, a series of 54 resected gliomas (37 from oligodendroglial lineage and…”
Get full text
Journal Article -
9
Epidermal growth factor receptor extracellular domain mutations in primary glioblastoma
Published in Neuropathology and applied neurobiology (01-04-2009)“…Aims: Novel missense mutations of the epidermal growth factor receptor (EGFR) extracellular domain have been recently described in a large series of…”
Get full text
Journal Article -
10
A uniform activated B-cell–like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases
Published in Blood (01-01-2006)“…Most primary central nervous system lymphomas (PCNSLs) in immunocompetent patients are diffuse large B-cell lymphomas (DLBCLs), characterized by poor…”
Get full text
Journal Article -
11
Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis
Published in Neuro-oncology (Charlottesville, Va.) (01-01-2011)“…Extensive genomic and gene expression studies have been performed in gliomas, but the epigenetic alterations that characterize different subtypes of gliomas…”
Get full text
Journal Article -
12
Prognostic impact of molecular markers in a series of 220 primary glioblastomas
Published in Cancer (15-05-2006)“…BACKGROUND In contrast to oligodendrogliomas, molecular predictors of prognosis have not been consistently found in glioblastomas. However, genetic studies…”
Get full text
Journal Article -
13
Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas
Published in Oncogene (25-03-2004)“…RASSF1A is a major tumor suppressor gene located at 3p21.3. We investigated the role of aberrant promoter region hypermethylation of RASSF1A in a large series…”
Get full text
Journal Article -
14
Chromosome 1p loss: A favorable prognostic factor in low-grade gliomas
Published in Annals of neurology (01-08-2005)“…Search for loss of heterozygosity on chromosomes 1p, 9p, 10q, and 19q, epidermal growth factor receptor (EGFR) gene amplification, and p53 expression was…”
Get full text
Journal Article -
15
Chromosome 9p and 10q losses predict unfavorable outcome in low-grade gliomas
Published in Neuro-oncology (Charlottesville, Va.) (01-01-2010)“…The loss of chromosomes 1p-19q is the only prognostic molecular alteration identified in low-grade gliomas (LGGs) to date. Search for loss of heterozygosity…”
Get full text
Journal Article -
16
Lymphomes intracrâniens du sujet immunocompétent
Published in EMC. Neurologie (01-05-2005)“…Les lymphomes intracrâniens sont représentés dans leur grande majorité par les lymphomes cérébraux primitifs (LCP) dont l’incidence a considérablement augmenté…”
Get full text
Journal Article -
17
Gliomes de bas grade : corrélations histo-moléculaires
Published in Neuro-chirurgie (01-02-2005)Get full text
Journal Article -
18
Distinct responses of xenografted gliomas to different alkylating agents are related to histology and genetic alterations
Published in Cancer research (Chicago, Ill.) (01-07-2004)“…A series of 12 human gliomas was established as xenografts in nude mice and used to evaluate the relationship between histology, genetic parameters, and…”
Get full text
Journal Article -
19
Influence of MDM2 SNP309 alone or in combination with the TP53 R72P polymorphism in oligodendroglial tumors
Published in Brain research (10-03-2008)“…Abstract The transcription factor p53 and its negative regulator MDM2 are pivotal in normal and cancer cells biology. Recently, a functional single-nucleotide…”
Get full text
Journal Article -
20
Loss of 22q chromosome is related to glioma progression and loss of 10q
Published in Journal of neuro-oncology (01-02-2006)“…Loss of heterozygosity (LOH) of chromosome 22q has been investigated in 160 gliomas. LOH at one or more microsatellite increased with increasing grade of the…”
Get full text
Journal Article